Thyroid papillary carcinoma and hashimoto's autoimmune thyroiditis in patients operated on thyroid diseases in the precarpathian endemic goiter region.

Authors

DOI:

https://doi.org/10.26641/1997-9665.2019.3.22-25

Keywords:

thyroid gland, thyroid papillary carcinoma, Hashimoto's autoimmune thyroiditis, focal thyroiditis

Abstract

Background. A feature of thyroid pathology in the endemic goiter region is the combination in one patient of several diseases of the thyroid gland, in particular thyroid papillary carcinoma and Hashimoto’s autoimmune thyroiditis. Objective. To determine the frequency and morphological features of thyroid papillary carcinoma and Hashimoto's autoimmune thyroiditis in surgically treated patients with thyroid diseases in the Precarpathian endemic goiter region. Methods. The results of pathohistological examinations of 1348 patients operated on thyroid diseases at the Lviv Regional Clinical Hospital and the Military Medical Clinical Center of the Western Region in 2014-2018 were analyzed. Results. Among 1348 patients operated on for thyroid disease Hashimoto's autoimmune thyroiditis was found in 61 cases (4.5 %), focal thyroiditis - in 114 cases (8.5 %), thyroid papillary carcinoma - in 245 cases (18.2%), thyroid papillary carcinoma of all histological variants except papillary microcarcinoma - in 204 cases (15.1 %) and papillary microcarcinoma - in 41 cases (3.0 %). Among the total number of operated patients in 70 cases (5.2%), in each individual patient both Hashimoto's autoimmune thyroiditis or focal thyroiditis in association with thyroid papillary carcinoma were detected. Conclusion. Residents of the Precarpathian endemic goiter region operated on thyroid diseases often have cases of a combination of Hashimoto's autoimmune thyroiditis and focal thyroiditis with thyroid papillary carcinoma. These cases need further study to improve their diagnosis and treatment.

References

  1. Harach HR, Williams ED. Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol (Oxf). 1995;43(6):701-6.
  2. Lai X, Xia Y, Zhang B, Li J, Jiang Y. A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017;8(37):62414-62424. doi: 10.18632/oncotarget.
  3. Molnár C, Molnár S, Bedekovics J, Mokánszki A, Győry F, Nagy E, Méhes G. Thyroid carcinoma coexisting with Hashimoto's thyreoiditis: clinicopathological and molecular characteristics clue up pathogenesis. Pathol Oncol Res. 2019;25(3):1191-1197. doi: 10.1007/s12253-019-00580-w.
  4. Moon S, Chung HS, Yu JM, Yoo HJ, Park JH, Kim DS, Park YJ. Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies. Endocrinol Metab (Seoul). 2018;33(4):473-484. doi: 10.3803/EnM.2018.33.4.473.
  5. Noureldine S I, Tufano R P. Association of Hashimoto's thyroiditis and thyroid cancer. Curr Opin Oncol. 2015;27(1):21-25. doi:10.1097/CCO.0000000000000150
  6. Pospishil Y. O., Vovk V. I., Omelyash U. V. Pathomorphosis of thyroid tumors in Precarpathian endemic goiter region in 2000-2010 and 2010-2012. Clinical endocrinology and endocrine surgery. 2018;3(63):64-71. Ukrainian. DOI: https://doi.org/10.24026/1818-1384.3(63).2018.142714.
  7. Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto's thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. 2017;7:53. doi: 10.3389/fonc.2017.00053. eCollection 2017.
  8. Ma H, Yan J, Zhang C, Qin S, Qin L, Liu L, Wang X, Li N. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis. Int J Clin Exp Pathol. 2014;7(11):7999-8007
  9. Jackson D, Handelsman RS, Farrá JC, Lew JI. Increased incidental thyroid cancer in patients with subclinical chronic lymphocytic thyroiditis. J Surg Res. 2019;245:115-118. doi: 10.1016/j.jss.2019.07.025
  10. Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab. 2006 ;91(6):2414-2423
  11. Uhliarova B., Hajtman A. Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma. Brazilian journal of otorhinolaryngology. 2018;(6):729-735. DOI10.1016/j.bjorl.2017.08.012
  12. Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, LiVolsi V, Lushnikov E, Rosai J, Tronko MD, Tsyb AF, Vowler SL, Thomas GA. Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid. 2008;18(8):847-852. doi: 10.1089/thy.2008.0039

Downloads

How to Cite

Vovk, V. I., & Omelyash, U. V. (2019). Thyroid papillary carcinoma and hashimoto’s autoimmune thyroiditis in patients operated on thyroid diseases in the precarpathian endemic goiter region. Морфологія / Morphologia / Morfologìâ, 13(3), 22–25. https://doi.org/10.26641/1997-9665.2019.3.22-25

Issue

Vol. 13 No. 3 (2019)

Section

Статті

License

Copyright (c) 2019 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.